← Back to all trials
Completed
NCT06333145
ED90 of Remimazolam Anesthesia Induction in Drug-induced Sleep Endoscopy in Adults
Conditions: Effect of Drug
Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: No
Phase: PHASE4
Enrollment: 165
Sponsor: Tongji Hospital
Location: Tongji Hospital Wuhan Hubei
Summary
Exploring the ED90 of remimazolam in Drug-induced Sleep Endoscopy in adults at different BMI groups.
Eligibility Criteria
Inclusion Criteria:
* 1\. Age 18-65 years old, 2. ASA Ⅰ-Ⅲ level; 3. Sign an informed consent form.
Exclusion Criteria:
* 1.A history of central nervous system diseases, cognitive disorders, mental disorders, or communication disorders; 2.serious cardiovascular, respiratory, liver or kidney disease; 3.Anticipated need for tracheal intubation or laryngeal mask; 4.Allergic to benzodiazepines and opioids; 5.Those who have taken sedative, analgesic or antidepressant drugs within 24 hours; 6.Abnormal liver and kidney function; 7.Recently participated in other clinical studies.
Source: ClinicalTrials.gov (NCT06333145). StuddyBuddy aggregates publicly available trial information.